Antimicrobial | E. coli (%) | Klebsiella (%) |
Ceftazidime (CAZ) Resistance Intermediate Susceptible |
6 (5.0) 0 115 (95.0) |
14 (8.5) 3 (1.8) 148 (89.7) |
Cefpodoxime (CPD) Resistance Intermediate Susceptible |
24 (19.8) 23 (19.0) 74 (61.2) |
44 (26.7) 15 (9.1) 106 (64.2) |
Cefoxitin (FOX) Resistance Intermediate Susceptible |
15 (12.4) 2 (1.7) 104 (86.0) |
20 (12.1) 1 (0.6) 144 (87.3) |
Cefepime (FEP) Resistance Intermediate Susceptible |
16 (13.2) 39 (32.2) 66 (54.5) |
30 (18.2) 61 (37.0) 74 (44.8) |
Ciprofloxacin (CIP) Resistance Intermediate Susceptible |
4 (3.3) 2 (1.7) 115 (95.0) |
4 (2.4) 4 (2.4) 157 (95.2) |
Amoxicilin clavulanic acid (AMC) Resistance Intermediate Susceptible |
15 (12.4) 18 (14.9) 88 (72.7) |
19 (11.5) 18 (10.9) 128 (77.6) |
Tetracycline (T) Resistance Intermediate Susceptible |
33 (27.3) 6 (5.0) 82 (67.8) |
41 (24.8) 13 (7.9) 111 (67.3) |
Meropenem (MRP) Resistance Intermediate Susceptible |
2 (1.7) 19 (15.7) 100 (82.6) |
3 (1.8) 51 (30.9) 111 (67.3) |
Streptomycin (S) Resistance Intermediate Susceptible |
55 (45.5) 59 (48.8) 7 (5.8) |
75 (45.5) 80 (48.5) 10 (6.1) |
Nalidixic acid (NA) Resistance Intermediate Susceptible |
11 (9.1) 0 110 (90.9) |
14 (8.5) 2 (1.2) 149 (90.3) |
Cloramphenical (C) Resistance Intermediate Susceptible |
7 (5.8) 2 (1.7) 112 (92.6) |
13 (7.9) 4 (2.4) 148 (89.7) |